News Europe: thumbs up for Roche's Hemlibra, Chiesi rare disease ... Drug has been approved in US since November
News EU regulators back Chiesi drug for rare inherited disease Decision paves way for licence to treat alpha-mannosidosis,
News Verona pushes on with COPD drug after £70m fundraiser UK biotech hopes RPL554 could be a disease modifying drug.
News European regulators back Chiesi COPD triple therapy Chiesi takes on Seretide and other lung drugs with Trimbow.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
